Collaboration, partnership, and clinical integration are key.

At AGBT 2026, Singular Genomics is bringing population-scale spatial to the forefront, spotlighting a foundation-scale colorectal cancer initiative from Weill Cornell Medicine researchers Chris Mason ...

When people think of genomics, they typically don’t visualize the primary care setting — but Northshore–Edward Elmhurst Health is trying to change that. Genomics is a key part of the health system’s ...

Forbes contributors publish independent expert analyses and insights. Steven covers accessibility and assistive technologies. Aug 07, 2023, 01:54pm EDT Aug 07, 2023, 03:58pm EDT This article is more ...

Every living organism has its own genetic "blueprint": the source code for how it grows, functions and reproduces. This ...

In this interview, Chris Roberts of Aventa Genomics highlights the groundbreaking Aventa FusionPlus test, detailing its superior ability to detect gene fusions in cancer diagnostics and its pivotal ...

Spatial genomics is a cutting-edge field that combines genomics and spatial analysis to investigate the role of genomic features in disease at single-cell resolution. Spatial genomics is a field of ...

Current Genomics is now accepting submissions. This journal publishes high-impact research across genome science, including ...

10x Genomics is stepping up to buy Scale Biosciences and its single-cell profiling solutions, with plans to implement them within the company’s Chromium platform. The deal for the recent Fierce ...

In many countries, newborn screening programmes test babies for certain inherited conditions shortly after birth.

10x Genomics has impressive financials but isn't expected to be profitable until at least 2028, posing significant investment risks. The company's growth heavily relies on its Chromium platform, with ...

Biotech company 10x Genomics (NASDAQ:TXG) reported in Q4 CY2025, but sales were flat year on year at $166 million. The ...